Acute myocardial infarction: is streptokinase really as effective as tissue plasminogen activator?
Vine
D L
DL
Department of Medicine, University of Kansas School of Medicine-Wichita 67214.
D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D010446:Peptide Fragments / Q000627:therapeutic use*; D013205:Staphylococcal Protein A / Q000627:therapeutic use*; D013300:Streptokinase / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D010446:Peptide Fragments; D013205:Staphylococcal Protein A; D006493:Heparin; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; C059835:tissue plasminogen activator-(staphylococcal A, B fragment) dimer